Frontotemporal Dementia Research Unit

Frontotemporal dementia is the second most common neurodegenerative dementing disorder. Our research focuses on two main areas: improving the diagnostic process through the use of biomarkers and understanding the core mechanisms of the disease. To achieve these aims, we use a variety of methods, including PET, MRI, and genetic analyses.

Our research contributes to improved diagnosis of frontotemporal dementia through biomarker-based disease classification. Furthermore, exploring how neurodevelopment impacts brain reserve in neurodegeneration will contribute to the understanding of the disease. Our research on the ethical framework to include patients with frontotemporal dementia in treatment trials, who often have loss of disease insight, is crucial for developing treatments.